Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Retina Vitreous Associates Medical Group, Beverly Hills, California Spencer Center for Vision Research, Palo Alto, California University of Michigan Kellogg Eye Center, Ann Arbor, Michigan Age range
55 Years and older
Last updated October 2025